News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

King Pharmaceuticals®, Inc. Announces the Discontinuation of Florinef (fludrocortisone acetate tablets, USP)


6/8/2007 3:25:23 PM

San Francisco – King Pharmaceuticals announced the discontinuation of Florinef (fludrocortisone acetate tablets, USP) on June 7, 2007. Florinef Acetate is indicated as a therapy in the treatment of adrenocortical insufficiency in Addison’s disease and for the treatment of salt-losing adrenogenital syndrome. To view the letter to the health care provider, please visit: http://www.fda.gov/cder/drug/shortages/florinef.pdf

Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES